drugset / Trial / NCT05917964
A Food Effect Study of LP-168 Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, two-period, two-sequence two-treatment crossover design food effect study to evaluate the pharmacokinetic profile of LP-168 tablets in healthy subjects after single oral administration under fasted and fed conditions
Timeline
- Start
- 2023-06-21
- Primary completion
- 2023-08-21
- Completion
- 2023-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rocbrutinib | Small molecule | 150 mg | Oral |